323 related articles for article (PubMed ID: 32513132)
1. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
Gupta GK; Agrawal T; Pilichowska M
BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
[TBL] [Abstract][Full Text] [Related]
2. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.
Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M
Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121
[TBL] [Abstract][Full Text] [Related]
3. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
[No Abstract] [Full Text] [Related]
4. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
[TBL] [Abstract][Full Text] [Related]
5. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
6. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
7. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
[TBL] [Abstract][Full Text] [Related]
8. Role of mast cells in fibrosis of classical Hodgkin lymphoma.
Nakayama S; Yokote T; Hiraoka N; Nishiwaki U; Hanafusa T; Nishimura Y; Tsuji M
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):603-611. PubMed ID: 27095287
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.
Assis MC; Campos AH; Oliveira JS; Soares FA; Silva JM; Silva PB; Penna AD; Souza EM; Baiocchi OC
Med Oncol; 2012 Dec; 29(5):3614-9. PubMed ID: 22791223
[TBL] [Abstract][Full Text] [Related]
10. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
Loo EY; Medeiros LJ; Aladily TN; Hoehn D; Kanagal-Shamanna R; Young KH; Lin P; Bueso-Ramos CE; Manning JT; Patel K; Thomazy V; Brynes RK; Goswami M; Fayad LE; Miranda RN
Am J Surg Pathol; 2013 Aug; 37(8):1290-7. PubMed ID: 23774171
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
12. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Marshall A; Chavez EA; Miyata-Takata T; Ben-Neriah S; Unrau D; Telenius A; Boyle M; Weng AP; Savage KJ; Scott DW; Farinha P; Shah SP; Nelson BH; Steidl C
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615710
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly.
Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S
J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus.
Zameer MA; Premalata CS; Arunakumari B; Appaji L; Rao CR
Pediatr Hematol Oncol; 2015 May; 32(4):229-38. PubMed ID: 25252151
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD47 antigen in Reed-Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma.
López-Pereira B; Fernández-Velasco AA; Fernández-Vega I; Corte-Torres D; Quirós C; Villegas JA; Palomo P; González S; González AP; Payer Á; Bernal T; Moro-García MA; Alonso-Arias R; Alonso-Álvarez S; Colado E
Clin Transl Oncol; 2020 May; 22(5):782-785. PubMed ID: 31359339
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P
Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
